KingHoves: JIMHO: Being in a pre-phase 1 trial situation (with admittedly a lot of future potential), I do NOT find the current valuation of ABOVE
A$ 50 mio. as being LOW or DEPRESSED at all?! In fact it does value NSB relatively highly at this early stage.
I remember when I was in Imugene in the early days under the new leadership: Then their market cap was WAY lower than 50 mio. ....
Just my musings as a non-holder. Make of it what you want.
Wishing all holders of NSB best of luck.
wasa
Potential 100 bagger Biotech missed by the market, page-1359
-
- There are more pages in this discussion • 160 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
